Some pharmaceutical companies are cutting deals with insurers to favor brand-name products over cheaper versions.
Lawmakers call on President Trump to honor his campaign promises and back their bill when he addresses Congress Tuesday night.
As it readies for battle with President Trump over drug prices, the pharmaceutical industry is deploying economists and health care experts from top universities.
Sen. Cory Booker and others drew sharp rebuke from observers who pointed out that many who voted "no" receive substantial contributions from the pharmaceutical industry.
The Vermont senator rallies his still-faithful base in campaigning for a California proposition aimed at Big Pharma.
This new price gouge is the latest example of a corrupt system that hurts regular Americans—but we will hold accountable those who are responsible.
The health professions make a grave mistake when they treat mental illnesses as “discrete brain conditions that are largely genetically determined and barely influenced by the slings and arrows of misfortune,” writes clinical psychologist and researcher Richard Bentall.
Emergency room doctors are reaching for medicines that aren’t there after drug shortages jumped more than fivefold between 2008 and 2014. And experts say drug companies are to blame.
In a recent earnings call, a top official at pharmaceutical giant Johnson & Johnson dismissed questions about drug price reform and described the company as “responsible” in its pricing.